Vidal Sassoon
This article was originally published in The Rose Sheet
Executive Summary
Procter & Gamble plans to reintroduce hair care line in the U.S. in the future and has a "game plan to win with the brand" globally, firm says. Consumer products giant retained global licensing rights to hair care brand as part of lawsuit settlement with hair stylist Vidal Sassoon, announced Sept. 1. P&G discontinued VS Sassoon in the U.S. in 2002, although the line still is marketed internationally (1"The Rose Sheet" Nov. 11, 2002, p. 7). Sassoon sued P&G last year, claiming the company neglected his namesake brand in favor of brands like Pantene. He specifically alleged breach of fiduciary duty, engagement in constructive fraud, actual fraud and breach of implied covenant, and was seeking hundreds of millions of dollars in damages in addition to termination of the licensing agreement (2"The Rose Sheet" April 7, 2003, p. 6)...
You may also be interested in...
Vidal Sassoon Aims For Clean Break With P&G In Lawsuit
Celebrity hair stylist Vidal Sassoon is seeking to terminate his licensing arrangement with Procter & Gamble and restore the Vidal Sassoon hair care brand in a lawsuit filed April 1 in Los Angeles federal court
P&G Gives Hair Care Portfolio A Trim; VS Sassoon To Be Discontinued
Procter & Gamble will suspend its VS Sassoon hair care line in the U.S. due to declining sales, the company said. P&G plans to stop shipping the line early next year, but retailers are expected to sell through remaining stock, the firm stated
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.